This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Transcatheter Heart Valve Replacement (TAVI) Market

Transcatheter Heart Valve Replacement Market By Product, Surgical Approach, Application & Region - Forecast 2022 - 2032

Market Insights on Transcatheter Heart Valve Replacement (TAVI) covering sales outlook, demand forecast & up-to-date key trends

Transcatheter Heart Valve Replacement (TAVI) Market Overview

The transcatheter heart valve replacement market is predicted to advance at an impressive CAGR of 12% from 2022 to 2032.

Attributes

Details

Transcatheter Heart Valve Replacement Market (CAGR)

12%

Transcatheter Heart Valve Replacement Market (2026)

US$ 19 Bn

The demand for transcatheter heart valves is being boosted by technological advancements in surgical procedures.

Furthermore, a favourable reimbursement scenario and growing manufacturer interest are spiking the sales of transcatheter heart valves.

The most recent trends in the global transcatheter heart valve replacement market is being driven by increased product development initiatives by companies resulting in increased transcatheter heart valve replacement market share.

For instance, JenaValve Technology, Inc., the manufacturer and developer of the JenaValve Pericardial TAVR system, received the U.S. FDA's "Breakthrough Device" designation.

Sales of transcatheter pulmonary valves are expected to witness a huge surge as transcatheter pulmonary valves are in high demand owing to their use in the treatment of patients with narrowed or leaky pulmonary valves.

These valves are also useful in reducing the number of heart surgeries required by a patient over the course of his or her life thereby surging the sales of transcatheter heart valves.

As a result, these factors contribute to the growing demand for transcatheter heart valves, propelling segment growth during the forecast period.

The increasing number of government initiatives aimed at valvular disease management is a major factor accelerating the growth of the hospitals segment in the transcatheter heart valve replacement market.

Transcatheter heart valve replacement is emerging as a new market frontier and demand for transcatheter heart valves as a result of increased research investment by major manufacturers in order to enter into strategic collaborations.

The launch of new products for transcatheter heart valve replacement is expected to boost the sales of transcatheter heart valves.

The introduction of transcatheter technology at a time when people are rapidly shifting toward minimally invasive treatment options spikes the demand for transcatheter heart valves.

Medtronic, for example, announced the launch of Evolut PRO+, a transcatheter heart valve replacement system, in the United States.

Furthermore, sales of transcatheter heart valves are likely to skyrocket as proven clinical studies highlight the safety of transcatheter heart valves when compared to surgical valves, and fewer complications are expected to fuel the market.

Customize this Report

Let us know your requirement to get
100% FREE customization

What are the Key Dynamics of the Transcatheter Heart Valve Replacement Market?

Demand for transcatheter heart valves is primarily driven by people with valvular heart disease. Around 5% of the global population aged above 65 years is at the risk of developing valvular heart disease.

If the heart valve is not replaced or repaired, 50% of the valvular heart disease patients would not survive, in turn increasing the sales of transcatheter heart valves globally.

The transcatheter heart valve is used in transcatheter aortic valve replacement procedure for valvular heart disease patients who are unable to sustain open-heart surgery which puts transcatheter heart valve replacement market in spotlight.

For instance, patients having heart, lung kidney diseases or diabetic patients face complications in open-heart surgery due to which transcatheter aortic replacement is the viable option which augments the sales of transcatheter heart valves.

Demand for transcatheter heart valves is also increasing as transcatheter aortic valve replacement has been proven to have higher survival rates in valvular heart disease patients.

The recovery period after insertion of transcatheter heart valve is seven to eight days which is less than other surgical procedures which is a significant impediment to the demand for transcatheter heart valves and sales of transcatheter heart valves.

Sales of transcatheter heart valves is also impacted by the limitation of the transcatheter heart valve replacement market which poses risk as there can be problems related to replacement of valve and its slipping.

Also, there is high risk of blood vessel tearing and infection during the transcatheter heart valve replacement procedure which negatively affects the demand for transcatheter heart valves.

How Does the Transcatheter Aortic Valve Act as an Efficient Transcatheter Heart Valve Replacement?

Transcatheter aortic valve replacement is a minimally invasive procedure and is an efficient alternative for open-heart surgery. As a result, the overall demand for transcatheter heart valves spike.

With number of high-risk severe aortic stenosis patient going for TAVI implantation, it is estimated that in the forecast years, patient with low-risk will opt for such procedures due to its nature of implantation.

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

Why is Europe Leading the Transcatheter Heart Valve Replacement Market?

Europe is the major market for transcatheter heart valve replacement and the demand for transcatheter heart valves in Europe is attributed to the technology advancements in that region.

With the introduction of transcatheter heart valve replacement in the United States in 2011 and patient with severe aortic stenosis with inoperable conditions opting minimally invasive surgery, sales of transcatheter heart valves is likely to surge.

How is the Competition Landscape in the Transcatheter Heart Valve Replacement Market?

The major transcatheter heart valve replacement market share is held by two players namely Edward Lifesciences LLC and Medtronic Inc.

Abbott, HighLife Medical, 4C Medical Technologies, JC Medical, LivaNova, Boston Scientific, Edwards Lifesciences, Medtronic plc, and Neovasc are some other players in the transcatheter heart valve replacement market.

In order to maintain a competitive advantage over their peers and maintain a large transcatheter heart valve replacement market share, these major market players are pursuing a number of strategic mergers, acquisitions, collaborations etc.

These players are also making investments that will allow them to capture the greatest possible transcatheter heart valve replacement market share.

One of the recent developments in the transcatheter heart valve replacement market is when Abbott announced that the TriClip Transcatheter Tricuspid Valve Repair System has received CE Mark approval for use in Europe and other countries that recognise CE Mark as a non-surgical treatment for people.

The strategic move will help the company improve its product portfolio and expand its geographical presence couple with major transcatheter heart valve replacement market share.

Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

Scope Of Report

Report Attribute 

Details

Growth rate 

CAGR of 12% from 2022 to 2032

Base year for estimation 

2021 

Historical data 

2015 - 2020 

Forecast period 

2022 - 2032 

Quantitative units 

Revenue in USD billion, volume in kilotons, and CAGR from 2022 to 2032 

Report coverage 

Revenue forecast, volume forecast, company ranking, competitive landscape, growth factors, and trends, Pricing Analysis,  

Segments covered 

Product, Surgical Approach, Application, Region 

Regional scope 

North America; Western Europe, Eastern Europe, Middle East, Africa, ASEAN, South Asia, Rest of Asia, Australia and New Zealand 

Country scope 

U.S.; Canada; Mexico; Germany; U.K.; France; Italy; Spain; Russia; Belgium; Poland; Czech Republic; China; India; Japan; Australia; Brazil; Argentina; Colombia; Saudi Arabia; UAE; Iran; South Africa 

Key companies profiled 

Abbott, HighLife Medical, 4C Medical Technologies, JC Medical, LivaNova, Boston Scientific, Edwards Lifesciences, Medtronic plc, and Neovasc

Customization scope 

Free report customization (equivalent to up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope. 

Pricing and purchase options 

Avail customized purchase options to meet your exact research needs.

Frequently Asked Questions

The transcatheter heart valve replacement market is anticipated to register a CAGR of 12% during the forecast period.

The value of the transcatheter heart valve replacement market accounted for US$ 6.3 Bn in 2019.

The major transcatheter heart valve replacement market share is held by two players namely Edward Lifesciences LLC and Medtronic Inc.

Table of Content

NA

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

NA

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst
List of Charts

NA

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports
Google translate

Transcatheter Heart Valve Replacement (TAVI) Market